A detailed history of Headinvest, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Headinvest, LLC holds 10,807 shares of ABBV stock, worth $1.81 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
10,807
Previous 11,577 6.65%
Holding current value
$1.81 Million
Previous $1.73 Million 2.96%
% of portfolio
0.36%
Previous 0.38%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

SELL
$137.6 - $154.97 $105,952 - $119,326
-770 Reduced 6.65%
10,807 $1.67 Million
Q3 2023

Dec 11, 2023

SELL
$133.59 - $154.65 $133,055 - $154,031
-996 Reduced 7.92%
11,577 $1.73 Million
Q2 2023

Aug 23, 2023

SELL
$132.51 - $164.9 $136,485 - $169,847
-1,030 Reduced 7.57%
12,573 $1.69 Million
Q1 2023

May 17, 2023

SELL
$144.61 - $166.54 $112,940 - $130,067
-781 Reduced 5.43%
13,603 $2.17 Million
Q4 2022

Feb 13, 2023

SELL
$138.31 - $165.87 $3,872 - $4,644
-28 Reduced 0.19%
14,384 $2.33 Million
Q3 2022

Dec 28, 2022

BUY
$134.21 - $153.93 $9,797 - $11,236
73 Added 0.51%
14,412 $1.93 Million
Q2 2022

Aug 12, 2022

SELL
$137.62 - $174.96 $5,367 - $6,823
-39 Reduced 0.27%
14,339 $2.2 Million
Q1 2022

May 13, 2022

BUY
$131.98 - $163.75 $19,533 - $24,235
148 Added 1.04%
14,378 $2.33 Million
Q4 2021

Feb 11, 2022

BUY
$107.43 - $135.93 $39,749 - $50,294
370 Added 2.67%
14,230 $1.93 Million
Q3 2021

Nov 16, 2021

BUY
$106.4 - $120.78 $12,980 - $14,735
122 Added 0.89%
13,860 $1.5 Million
Q2 2021

Aug 30, 2021

BUY
$105.21 - $117.21 $16,938 - $18,870
161 Added 1.19%
13,738 $1.55 Million
Q1 2021

May 13, 2021

BUY
$102.3 - $112.62 $339,942 - $374,236
3,323 Added 32.41%
13,577 $1.47 Million
Q4 2020

Feb 16, 2021

BUY
$80.49 - $108.67 $155,184 - $209,515
1,928 Added 18.8%
12,182 $1.31 Million
Q4 2020

Feb 16, 2021

SELL
$80.49 - $108.67 $155,184 - $209,515
-1,928 Reduced 15.83%
10,254 $898,000
Q3 2020

Nov 24, 2020

BUY
$85.91 - $100.83 $96,648 - $113,433
1,125 Added 12.32%
10,254 $898,000
Q2 2020

Aug 12, 2020

BUY
$73.37 - $98.18 $27,073 - $36,228
369 Added 4.21%
9,129 $896,000
Q1 2020

May 12, 2020

BUY
$64.5 - $97.79 $136,159 - $206,434
2,111 Added 31.75%
8,760 $667,000
Q1 2020

May 11, 2020

SELL
$64.5 - $97.79 $123,969 - $187,952
-1,922 Reduced 22.42%
6,649 $506,000
Q4 2019

Feb 14, 2020

BUY
$72.13 - $90.25 $2,163 - $2,707
30 Added 0.35%
8,571 $759,000
Q3 2019

Nov 21, 2019

BUY
$62.98 - $75.72 $109,081 - $131,147
1,732 Added 25.44%
8,541 $647,000
Q2 2019

Aug 22, 2019

BUY
$65.7 - $83.98 $10,512 - $13,436
160 Added 2.41%
6,809 $495,000
Q1 2019

May 15, 2019

SELL
$77.14 - $90.79 $512,903 - $603,662
-6,649 Reduced 50.0%
6,649 $536,000
Q4 2018

Feb 22, 2019

BUY
$77.85 - $96.01 $516,067 - $636,450
6,629 Added 99.4%
13,298 $1.23 Million
Q3 2018

Nov 14, 2018

SELL
$88.91 - $98.84 $9,602 - $10,674
-108 Reduced 1.59%
6,669 $631,000
Q2 2018

Aug 09, 2018

BUY
$89.78 - $106.23 $1,795 - $2,124
20 Added 0.3%
6,777 $628,000
Q1 2018

Apr 09, 2018

SELL
$92.01 - $123.21 $41,404 - $55,444
-450 Reduced 6.24%
6,757 $640,000
Q4 2017

Jan 30, 2018

SELL
$89.56 - $98.21 $17,912 - $19,642
-200 Reduced 2.7%
7,207 $697,000
Q3 2017

Nov 13, 2017

BUY
$69.85 - $89.22 $517,378 - $660,852
7,407
7,407 $668,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $296B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Headinvest, LLC Portfolio

Follow Headinvest, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Headinvest, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Headinvest, LLC with notifications on news.